lenabasum
Small moleculeexperimental
Clinical trial activity
3 trials · 8 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
2
Phase 4
0
Earliest trial started Dec 18, 2017 (NCT03398837)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
CCCCCCC(C)(C)c1cc(O)c2c(c1)OC(C)(C)[C@@H]1CC=C(C(=O)O)C[C@@H]21- Mol. weight
- 400.56 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL456341 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03813160 | Phase 3 | Dec 17, 2018 | Corbus Pharmaceuticals Inc., University of Pennsylvania, University of Pittsburgh |
| NCT03451045 | Phase 2 | Dec 22, 2017 | Corbus Pharmaceuticals Inc., Cystic Fibrosis Foundation Therapeutics, Imperial College London, Rainbow Baby and Children's Hospital |
| NCT03398837 | Phase 3 | Dec 18, 2017 | Corbus Pharmaceuticals Inc., Cornell University, University of London |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (8)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Corbus Pharmaceuticals Inc. | For profit | 3 | 3 | 2 | 2017 |
| Cornell University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Cystic Fibrosis Foundation Therapeutics | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Imperial College London | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Rainbow Baby and Children's Hospital | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of Pennsylvania | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of Pittsburgh | Academic/Hospital | 1 | 0 | 1 | 2018 |
8 organizations
Page 1 / 1